|
|
|
|
LEADER |
06379nma a2201765 u 4500 |
001 |
EB002050011 |
003 |
EBX01000000000000001193677 |
005 |
00000000000000.0 |
007 |
cr||||||||||||||||||||| |
008 |
220822 ||| eng |
020 |
|
|
|a books978-3-0365-2347-7
|
020 |
|
|
|a 9783036523484
|
020 |
|
|
|a 9783036523477
|
100 |
1 |
|
|a Feinle-Bisset, Christine
|
245 |
0 |
0 |
|a Appetite and Satiety Control-Gut Mechanisms
|h Elektronische Ressource
|
260 |
|
|
|a Basel, Switzerland
|b MDPI - Multidisciplinary Digital Publishing Institute
|c 2021
|
300 |
|
|
|a 1 electronic resource (454 p.)
|
653 |
|
|
|a aging
|
653 |
|
|
|a gastric motor function
|
653 |
|
|
|a TAS2R14
|
653 |
|
|
|a digestive well-being
|
653 |
|
|
|a FXR
|
653 |
|
|
|a cannabinoid CB1 receptor
|
653 |
|
|
|a protein
|
653 |
|
|
|a satiety
|
653 |
|
|
|a flavor
|
653 |
|
|
|a insulin resistance
|
653 |
|
|
|a gut-brain
|
653 |
|
|
|a weight management
|
653 |
|
|
|a hedonic sensations
|
653 |
|
|
|a miniature pig
|
653 |
|
|
|a scintigraphy
|
653 |
|
|
|a motivation
|
653 |
|
|
|a isoleucine
|
653 |
|
|
|a enteroendocrine cells
|
653 |
|
|
|a brainstem
|
653 |
|
|
|a GLP-1
|
653 |
|
|
|a bitter substances
|
653 |
|
|
|a single fiber recording
|
653 |
|
|
|a circadian
|
653 |
|
|
|a gastric band
|
653 |
|
|
|a gastrointestinal
|
653 |
|
|
|a cue reactivity
|
653 |
|
|
|a Roux-en-Y gastric bypass
|
653 |
|
|
|a gastric emptying breath test
|
653 |
|
|
|a sarcopenia
|
653 |
|
|
|a lifecourse
|
653 |
|
|
|a lixisenatide
|
653 |
|
|
|a sleeve gastrectomy
|
653 |
|
|
|a human studies
|
653 |
|
|
|a intestine
|
653 |
|
|
|a gastrointestinal tract
|
653 |
|
|
|a satiation
|
653 |
|
|
|a GIP
|
653 |
|
|
|a endocannabinoid
|
653 |
|
|
|a G-protein coupled receptors (GPCRs)
|
653 |
|
|
|a molecular imaging
|
653 |
|
|
|a bariatric surgery
|
653 |
|
|
|a PYY
|
653 |
|
|
|a abdominal wall activity
|
653 |
|
|
|a oral glucose tolerance test
|
653 |
|
|
|a glycaemic control
|
653 |
|
|
|a GLP-1r
|
653 |
|
|
|a texture
|
653 |
|
|
|a cephalic responses
|
653 |
|
|
|a type 2 diabetes
|
653 |
|
|
|a abdominal distension
|
653 |
|
|
|a Medicine and Nursing / bicssc
|
653 |
|
|
|a western diet
|
653 |
|
|
|a microbiome
|
653 |
|
|
|a ghrelin
|
653 |
|
|
|a TAS2R39
|
653 |
|
|
|a energy intake
|
653 |
|
|
|a intragastric meal retention
|
653 |
|
|
|a nutrient sensing
|
653 |
|
|
|a whey protein
|
653 |
|
|
|a functional gastrointestinal disorders
|
653 |
|
|
|a supplements
|
653 |
|
|
|a digestion
|
653 |
|
|
|a postprandial blood glucose
|
653 |
|
|
|a vagal afferents
|
653 |
|
|
|a CCK
|
653 |
|
|
|a n/a
|
653 |
|
|
|a brain stem
|
653 |
|
|
|a reward
|
653 |
|
|
|a functional brain imaging
|
653 |
|
|
|a intestinal brake
|
653 |
|
|
|a body weight
|
653 |
|
|
|a gastric accommodation
|
653 |
|
|
|a appetite regulation
|
653 |
|
|
|a gastric emptying
|
653 |
|
|
|a CB1 receptor
|
653 |
|
|
|a oro-sensory exposure
|
653 |
|
|
|a gastrointestinal hormones
|
653 |
|
|
|a hunger
|
653 |
|
|
|a carbohydrate
|
653 |
|
|
|a gastric bypass surgery
|
653 |
|
|
|a meal anticipation
|
653 |
|
|
|a vagus
|
653 |
|
|
|a enteroendocrine cells (EECs)
|
653 |
|
|
|a tastants
|
653 |
|
|
|a gut hormones
|
653 |
|
|
|a GLP1
|
653 |
|
|
|a hormones
|
653 |
|
|
|a pig model
|
653 |
|
|
|a sensory science
|
653 |
|
|
|a taste
|
653 |
|
|
|a hypothalamus
|
653 |
|
|
|a agonist
|
653 |
|
|
|a appetite
|
653 |
|
|
|a preference
|
653 |
|
|
|a amino acid
|
653 |
|
|
|a aversion
|
653 |
|
|
|a food ingestion
|
653 |
|
|
|a fat
|
653 |
|
|
|a gastric barostat
|
653 |
|
|
|a bile acids
|
653 |
|
|
|a chronic supplementation
|
653 |
|
|
|a nutrients
|
653 |
|
|
|a obesity
|
653 |
|
|
|a preclinical studies
|
653 |
|
|
|a TGR-5
|
653 |
|
|
|a brain areas
|
653 |
|
|
|a homeostatic sensations
|
653 |
|
|
|a feeding
|
653 |
|
|
|a postprandial responses
|
653 |
|
|
|a food intake
|
653 |
|
|
|a anorexia
|
653 |
|
|
|a postprandial symptoms
|
653 |
|
|
|a whey
|
653 |
|
|
|a duodenal jejunal and ileal brake
|
653 |
|
|
|a energy expenditure
|
653 |
|
|
|a circadian clock
|
653 |
|
|
|a nutrient preference
|
653 |
|
|
|a chemosensory
|
653 |
|
|
|a meal ingestion
|
653 |
|
|
|a TAS2R5
|
700 |
1 |
|
|a Horowitz, Michael
|
700 |
1 |
|
|a Feinle-Bisset, Christine
|
700 |
1 |
|
|a Horowitz, Michael
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b DOAB
|a Directory of Open Access Books
|
500 |
|
|
|a Creative Commons (cc), https://creativecommons.org/licenses/by/4.0/
|
028 |
5 |
0 |
|a 10.3390/books978-3-0365-2347-7
|
856 |
4 |
0 |
|u https://www.mdpi.com/books/pdfview/book/4619
|7 0
|x Verlag
|3 Volltext
|
856 |
4 |
2 |
|u https://directory.doabooks.org/handle/20.500.12854/77009
|z DOAB: description of the publication
|
082 |
0 |
|
|a 610
|
082 |
0 |
|
|a 333
|
082 |
0 |
|
|a 140
|
520 |
|
|
|a The prevalence of obesity and its comorbidities, particularly type 2 diabetes, cardiovascular and hepatic disease and certain cancers, continues to rise worldwide. Paradoxically, despite an increasingly obesogenic environment, particularly in Western societies, undernutrition is also extremely common. The application of novel, sophisticated techniques, particularly related to imaging and molecular biology, has substantially advanced our understanding of the mechanisms controlling appetite and energy intake. This has led to a redefinition of many concepts, including the relative importance of central versus peripheral mechanisms, recognising that the gastrointestinal (GI) tract, particularly gut hormones, plays a critical role. Given the major advance in knowledge in the field, this Special Issue provides a comprehensive overview of the GI mechanisms underlying the regulation of appetite and energy intake, as a series of definitive reviews by international authorities. The reviews address gut-related mechanisms, including nutrient sensing, gut hormones and GI motility, gut-brain communication, including the roles of the vagus and the modulation of reward perception, the roles of diet and the microbiota, as well as the abnormalities associated with eating disorders, specifically obesity and anorexia of ageing, and the beneficial effects of bariatric surgery. The reviews cover both preclinical research and studies in humans, and are complemented by a number of important original papers.
|